Get the Stockscreener App
2.43
6.18%
-0.16
After Hours:
2.40
-0.03
-1.23%
Revelation Biosciences Inc Stock (REVB) Forecast
The Revelation Biosciences Inc (REVB) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $21.27, representing a +775.45% increase from the current price of $2.43. The highest analyst price target is $23.90, and the lowest is $18.65.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month REVB Price Target
Average 17.09
(+603.18% Upside)
Is Revelation Biosciences Inc (REVB) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 34.84 | Neutral |
| STOCH(9,6) | 22.79 | Neutral |
| STOCHRSI(14) | 13.23 | Buy |
| MACD(12,26) | -0.1202 | Sell |
| ADX(14) | 26.01 | Sell |
| William %R | -98.91 | Buy |
| CCI(14) | -155.35 | Sell |
Buy: 2
Sell: 3
Neutral: 2
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.8885
Sell
|
2.7713
Sell
|
| MA20 |
2.9335
Sell
|
2.8833
Sell
|
| MA50 |
2.9504
Sell
|
3.2259
Sell
|
| MA100 |
4.0565
Sell
|
5.0394
Sell
|
| MA200 |
8.4834
Sell
|
13.59
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, REVB could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 13 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on REVB, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 34.84 indicates that REVB is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 22.79 indicates that REVB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 13.23 indicates that REVB is oversold. This suggests that REVB price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 26.01 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -155.35 indicates that REVB is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term REVB price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Revelation Biosciences Inc financial reports and earnings history, Revelation Biosciences Inc (REVB) stock could reach $94.29 by 2030, $244.21 by 2040 and $421.51 by 2050. See the projected annual prices until 2050 of the Revelation Biosciences Inc stock below:
- Revelation Biosciences Inc (REVB) is expected to reach an average price of $166.30 in 2035, with a high prediction of $167.23 and a low estimate of $166.65. This indicates an $6,744% rise from the last recorded price of $2.43.
- Revelation Biosciences Inc (REVB) stock is projected to chart a bullish course in 2040, with an average price target of $243.88, representing an $9,936% surge from its current level. The forecast ranges from a conservative $244.81 to a sky-high $244.21.
- Our analysts predict Revelation Biosciences Inc (REVB) to jump 13,173% by 2045, soaring from $312.65 to an average price of $322.55, potentially reaching $316.31. While $312.65 is the low estimate, the potential upside is significant.
- Revelation Biosciences Inc (REVB) stock is expected to climb by 2050, reaching an average of $396.83, a $16,230% jump from its current level. However, a wide range of estimates exists, with high and low targets of $421.51 and $401.50, respectively, highlighting the market's uncertainty.
Revelation Biosciences Inc Stock (REVB) Year by Year Forecast
Revelation Biosciences Inc Stock (REVB) Price Forecast for 2025
Revelation Biosciences Inc Stock (REVB) is expected to reach an average price of $20.70 in 2025, with a high prediction of $24.52 and a low estimate of $16.89. This indicates an +751.93% rise from the last recorded price of $2.43.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2025 | $24.35 | $18.65 | $23.90 | +901.99% |
| July, 2025 | $23.72 | $23.72 | $24.11 | +876.19% |
| August, 2025 | $22.58 | $22.82 | $23.24 | +829.39% |
| September, 2025 | $21.27 | $21.33 | $21.79 | +775.17% |
| October, 2025 | $19.63 | $19.74 | $20.90 | +707.82% |
| November, 2025 | $18.53 | $18.57 | $19.20 | +662.66% |
| December, 2025 | $16.86 | $16.89 | $18.14 | +593.66% |
Revelation Biosciences Inc Stock (REVB) Price Forecast for 2026
The predicted value for Revelation Biosciences Inc (REVB) in 2026 is set at an average of $21.99. Estimates vary from a peak of $43.70 to a trough of $0.2846, indicating an +804.95% surge from the present price of $2.43.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $15.64 | $15.64 | $16.47 | +543.47% |
| February, 2026 | $14.28 | $14.31 | $15.25 | +487.66% |
| March, 2026 | $12.96 | $13.04 | $13.88 | +433.48% |
| April, 2026 | $11.26 | $11.34 | $12.58 | +363.24% |
| May, 2026 | $9.9794 | $10.07 | $10.89 | +310.68% |
| June, 2026 | $8.6919 | $8.7014 | $9.6251 | +257.69% |
| July, 2026 | $4.4403 | $0.2846 | $17.44 | +82.73% |
| August, 2026 | $2.4779 | $3.3779 | $3.8059 | +1.97% |
| September, 2026 | $1.6911 | $2.0961 | $2.2705 | -30.41% |
| October, 2026 | $0.8937 | $1.0517 | $1.2518 | -63.22% |
| November, 2026 | $47.87 | $0.315 | $41.22 | +1,870% |
| December, 2026 | $49.73 | $39.21 | $43.70 | +1,946% |
Revelation Biosciences Inc Stock (REVB) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Revelation Biosciences Inc (REVB) is $52.71, with a high forecast of $63.70 and a low forecast of $41.71. This indicates an +2,069% increase from the last price of $2.43.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $45.61 | $49.05 | $49.44 | +1,777% |
| February, 2027 | $64.35 | $54.38 | $57.95 | +2,548% |
| March, 2027 | $65.05 | $64.71 | $63.70 | +2,577% |
| April, 2027 | $33.99 | $47.04 | $60.95 | +1,299% |
| May, 2027 | $57.68 | $41.71 | $55.78 | +2,273% |
| June, 2027 | $58.33 | $57.92 | $57.96 | +2,300% |
| July, 2027 | $60.13 | $57.32 | $58.07 | +2,375% |
| August, 2027 | $55.63 | $58.26 | $58.24 | +2,189% |
| September, 2027 | $55.90 | $56.04 | $55.42 | +2,200% |
| October, 2027 | $52.96 | $53.79 | $54.82 | +2,079% |
| November, 2027 | $48.42 | $50.69 | $52.25 | +1,892% |
| December, 2027 | $51.49 | $46.49 | $47.43 | +2,019% |
Revelation Biosciences Inc Stock (REVB) Price Forecast for 2028
In 2028, Revelation Biosciences Inc (REVB) is projected to reach an average price of $34.64, with a high projection of $50.73 and a low estimate of $18.56. This indicates an +1,326% rise from the last price of $2.43.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $49.45 | $49.57 | $50.73 | +1,935% |
| February, 2028 | $47.61 | $47.62 | $48.73 | +1,859% |
| March, 2028 | $44.32 | $44.54 | $46.82 | +1,724% |
| April, 2028 | $41.75 | $41.80 | $43.54 | +1,618% |
| May, 2028 | $38.46 | $38.50 | $41.06 | +1,483% |
| June, 2028 | $35.87 | $35.92 | $37.76 | +1,376% |
| July, 2028 | $33.26 | $33.30 | $35.16 | +1,269% |
| August, 2028 | $29.82 | $29.88 | $32.58 | +1,127% |
| September, 2028 | $27.18 | $27.20 | $29.13 | +1,019% |
| October, 2028 | $24.56 | $24.57 | $26.50 | +910.70% |
| November, 2028 | $21.00 | $21.04 | $23.84 | +764.10% |
| December, 2028 | $18.54 | $18.56 | $20.31 | +663.05% |
Revelation Biosciences Inc Stock (REVB) Price Forecast for 2029
The 2029 price forecast for Revelation Biosciences Inc Stock (REVB) is $53.92 on average, with a high prediction of $105.12 and a low estimate of $2.71. This represents an +2,119% increase from the previous price of $2.43.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $6.8493 | $8.1093 | $17.82 | +181.86% |
| February, 2029 | $10.13 | $10.23 | $11.33 | +317.06% |
| March, 2029 | $7.8096 | $7.9283 | $7.9158 | +221.38% |
| April, 2029 | $5.4248 | $5.4548 | $7.0409 | +123.24% |
| May, 2029 | $91.55 | $2.71 | $63.20 | +3,667% |
| June, 2029 | $80.83 | $95.78 | $89.87 | +3,226% |
| July, 2029 | $94.26 | $84.36 | $91.42 | +3,779% |
| August, 2029 | $102.41 | $97.50 | $96.59 | +4,114% |
| September, 2029 | $106.35 | $106.13 | $105.12 | +4,277% |
| October, 2029 | $81.75 | $86.43 | $102.28 | +3,264% |
| November, 2029 | $94.38 | $80.42 | $67.50 | +3,784% |
| December, 2029 | $95.45 | $94.93 | $93.56 | +3,828% |
Revelation Biosciences Inc Stock (REVB) Price Forecast for 2030
Revelation Biosciences Inc Stock (REVB) is expected to reach an average price of $75.27 in 2030, with a high forecast of $94.29 and a low forecast of $56.26. This signifies an +2,998% surge from the last price of $2.43.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $95.82 | $92.64 | $94.29 | +3,843% |
| February, 2030 | $92.55 | $93.15 | $92.70 | +3,709% |
| March, 2030 | $89.16 | $88.97 | $87.67 | +3,569% |
| April, 2030 | $85.03 | $85.64 | $86.66 | +3,399% |
| May, 2030 | $80.17 | $81.31 | $83.67 | +3,199% |
| June, 2030 | $73.04 | $74.34 | $76.80 | +2,906% |
| July, 2030 | $76.22 | $74.52 | $77.55 | +3,037% |
| August, 2030 | $72.85 | $73.11 | $75.17 | +2,898% |
| September, 2030 | $69.14 | $69.27 | $71.83 | +2,745% |
| October, 2030 | $64.11 | $64.16 | $67.98 | +2,538% |
| November, 2030 | $60.11 | $60.11 | $63.10 | +2,374% |
| December, 2030 | $56.23 | $56.26 | $59.04 | +2,214% |
17.27%
1.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):